ľ¹ÏÖ±²¥ logoľ¹ÏÖ±²¥

ľ¹ÏÖ±²¥ Ventures

ľ¹ÏÖ±²¥ Ventures (AHAV) is a platform that leads and coordinates the venture capital programs of the ľ¹ÏÖ±²¥.
heart graphic

What is ľ¹ÏÖ±²¥ Ventures?

The vision of ľ¹ÏÖ±²¥ Ventures builds upon the overall Association mission by funding programs that ensure the translation of high quality, evidence-based science, research and clinical know-how into actionable, meaningful, equitable and sustainable positive impact for patients and the health care system.




What is included within ľ¹ÏÖ±²¥ Ventures?

Currently, ľ¹ÏÖ±²¥ Ventures has two active programs:


ľ¹ÏÖ±²¥ Social Impact Funds

The ľ¹ÏÖ±²¥ Social Impact Funds, including the Bernard J. Tyson Social Impact fund, are, collectively an impact-focused venture fund investing in sustainable, scalable businesses that address social drivers of health. This fund invests in organizations that expand health access and quality; drive economic empowerment; and, address food insecurity.

Cardeation Capital

Cardeation Capital, a venture fund established in 2017 in collaboration with Aphelion Capital, Philips, UPMC and RCT Ventures. Cardeation invests in medical technology companies.

Contact Us

Lisa Suennen

Managing Partner
AHA Ventures

Gregory Mandell

Managing Director
AHA Ventures

ľ¹ÏÖ±²¥ Ventures is establishing several new programs that are expected to launch in Fiscal Year 2024-2025, including:

  • Go Red for Women Venture Fund, A venture fund that invests in companies that focus first, or substantially, in improving women’s cardiovascular health, brain health and related conditions, in alignment with the Association’s mission and its signature Go Red for Women initiative.

  • Venture Studio, An incubation program that focuses on identifying, building and launching innovative, impactful businesses. We leverage intellectual property and know-how from within the ľ¹ÏÖ±²¥ and from our scientific and clinical community to collaborate in the translation of evidence-based knowledge to high quality commercial enterprises.

Interested in learning more about future funding opportunities? We’d love to hear from you.